Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2025-12-25 @ 11:11 PM
Study NCT ID:
NCT06052293
Status:
COMPLETED
Last Update Posted:
2024-08-13
First Post:
2023-08-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1 Study to Assess Safety and Efficacy of ANG003
Sponsor:
Anagram Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2023-08-09
First Submit QC Date:
None
Study First Post Date:
2023-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-12
Last Update Post Date:
2024-08-13
Last Update Post Date Type:
ACTUAL